Auro Laboratories Quarterly Results for Trading Insights
In Sept 2025, Auro Laboratories (AUROLAB) reported revenue ₹10 Cr and net profit ₹1 Cr — revenue +233.3% YoY. For annual financials, live price and key ratios, visit AUROLAB company profile.
AUROLAB Quarterly Results — Revenue, Profit & EPS Highlights
Auro Laboratories latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with AUROLAB fundamental valuation to assess whether the stock is under or overvalued.
- Revenue of ₹10 Cr in Sept 2025 (+233.3% vs Jun 2025, +233.3% vs Sept 2024)
- Net Profit of ₹1 Cr in Sept 2025
- EBITDA of ₹3 Cr in Sept 2025
- Operating Margin of 27.0% in Sept 2025 (+26.0pp vs Jun 2025)
- Earnings Per Share of ₹1.15 in Sept 2025 (+776.5% vs Jun 2025)
Auro Laboratories Quarterly Results — Revenue, EBITDA, Net Profit & EPS
AUROLAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | Sept 2025 | Jun 2025 | Sept 2024 | Jun 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 10 | 3 | 3 | 6 | 233.3% | 233.3% |
| Net Profit (₹ Cr) | 1 | 0 | 0 | 1 | - | - |
| EBITDA (₹ Cr) | 3 | 0 | 1 | 2 | - | - |
| EPS (₹) | 1.15 | -0.17 | 0.57 | 1.21 | - | - |
| Operating Margin (%) | 27.0% | 1.0% | 23.0% | 23.0% | - | - |
AUROLAB Share Price Trend — 1-Year Movement Across Quarterly Results
Auro Laboratories 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Analyse AUROLAB ownership pattern to track promoter, FII and institutional holdings.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
AUROLAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Auro Laboratories latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹415,924.72 Cr | 1747.3 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.4 |
|
Divis Laboratories
Sept 2025 |
₹171,625.44 Cr | 6432.5 | 2,860 | 689 | +7.1% | - | 24.1% | 247.7 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹139,344.76 Cr | 4182.9 | 3,219 | 591 | +11.3% | - | 18.4% | 238.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹109,930.83 Cr | 1354.6 | 9,135 | 1,337 | +1.1% | - | 14.6% | 83.7 |
|
Lupin
Sept 2025 |
₹104,941.69 Cr | 2302.7 | 6,921 | 1,485 | +23.2% | - | 21.5% | 71.2 |
All amounts in ₹ Crores